We are glad to announce that the US association CMTA joined the European CMT Association as Associate Member.
The CMTA is the leading patient advocacy organization driving CMT research. Its mission is to develop treatments and a cure for the 3 million people worldwide who live with the disease while improving the quality of life for patients and their families.
The CMTA has invested $23.5 million in the search for a cure. Its Strategy to Accelerate Research (STAR) brings world-renowned CMT researchers, pharmaceutical and biotechnology partners, and patients to accelerate scientific breakthroughs.
The CMTA also offers community services, including 70 local branches, educational materials and patient conferences. To learn more about CMTA, click here.
The close ties that have united CMTA and the ECMTF since the beginning has led to the formalization of this relationship for the interest and benefit of CMT patients. Thank you, CMTA.
Together, we are stronger.